MedPath

GLOBAL MEDICAL SOLUTIONS SOUTHERN AUSTRALIA PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

26

Active:0
Completed:20

Trial Phases

4 Phases

Phase 1:6
Phase 2:3
Phase 3:5
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials

Phase 4
8 (36.4%)
Phase 1
6 (27.3%)
Phase 3
5 (22.7%)
Phase 2
3 (13.6%)

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Phase 1
Recruiting
Conditions
Gastric Cancer
Colorectal Cancer
Esophageal Cancer
Sarcoma
Metastatic Sarcoma
Pancreatic Cancer
First Posted Date
2024-03-07
Last Posted Date
2025-07-02
Lead Sponsor
Lantheus Medical Imaging
Target Recruit Count
32
Registration Number
NCT06298916
Locations
🇺🇸

BAMF Health, Inc., Grand Rapids, Michigan, United States

🇺🇸

UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange, California, United States

🇺🇸

Stanford Hospital & Clinics, Stanford, California, United States

and more 1 locations

PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer

Phase 4
Recruiting
Conditions
Prostate Cancer
Interventions
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]
First Posted Date
2023-10-10
Last Posted Date
2025-05-31
Lead Sponsor
Lantheus Medical Imaging
Target Recruit Count
274
Registration Number
NCT06074510
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Hoag Cancer Center, Irvine, California, United States

🇺🇸

Tower Urology, Los Angeles, California, United States

and more 11 locations

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Conditions
Castration-Resistant Prostatic Cancer
First Posted Date
2023-09-13
Last Posted Date
2025-01-13
Lead Sponsor
Lantheus Medical Imaging
Registration Number
NCT06033001
Locations
🇺🇸

Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

🇺🇸

Hartford HealthCare Cancer Institute at Hartford Hospital, Hartford, Connecticut, United States

🇺🇸

Florida Theranostics Cancer Center, Jupiter, Florida, United States

and more 4 locations

DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY

Phase 3
Completed
Conditions
Cardiac Disease
Interventions
First Posted Date
2018-10-25
Last Posted Date
2021-01-28
Lead Sponsor
Lantheus Medical Imaging
Target Recruit Count
160
Registration Number
NCT03719612
Locations
🇺🇸

Banner University of Arizona Medical Center, Tucson, Arizona, United States

🇺🇸

Cedars Sinai, Los Angeles, California, United States

🇺🇸

University of California-Irvine, Orange, California, United States

and more 12 locations

DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY

Phase 3
Completed
Conditions
Cardiac Disease
Interventions
First Posted Date
2018-06-27
Last Posted Date
2020-12-17
Lead Sponsor
Lantheus Medical Imaging
Target Recruit Count
153
Registration Number
NCT03571672
Locations
🇺🇸

Banner University of Arizona Medical Center, Tucson, Arizona, United States

🇺🇸

University of California-San Diego, San Diego, California, United States

🇺🇸

Alfieri Cardiology, Wilmington, Delaware, United States

and more 6 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.